EPZ: (2R)-2-{[(2R,3R,4R,5S,6R)-3-(acetylamino)-2-{[(S)-{[(R)-{[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoic acid
EPZ is a Ligand Of Interest in 9SQE designated by the Author
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Best-fitted instance in this entry | |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry | |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9SQE_EPZ_A_302 | 87% | 45% | 0.054 | 0.967 | 0.85 | 1.17 | 2 | 6 | 2 | 0 | 100% | 1 |
| 9SQE_EPZ_C_302 | 85% | 41% | 0.058 | 0.963 | 0.84 | 1.35 | 1 | 5 | 0 | 0 | 100% | 1 |
| 9SQE_EPZ_B_302 | 80% | 47% | 0.066 | 0.957 | 0.78 | 1.18 | 1 | 5 | 0 | 0 | 100% | 1 |
| 9SQG_EPZ_A_301 | 79% | 50% | 0.069 | 0.955 | 0.8 | 1.02 | - | 5 | 0 | 0 | 100% | 1 |
| 9SZL_EPZ_B_301 | 74% | 41% | 0.075 | 0.945 | 0.86 | 1.32 | 1 | 6 | 3 | 0 | 100% | 1 |
| 7F3V_EPZ_C_301 | 96% | 55% | 0.04 | 0.986 | 0.74 | 0.83 | 1 | 1 | 0 | 0 | 100% | 1 |
| 6Q0A_EPZ_A_502 | 93% | 59% | 0.047 | 0.981 | 0.57 | 0.8 | - | 1 | 0 | 0 | 100% | 1 |
| 3SU9_EPZ_A_427 | 92% | 27% | 0.047 | 0.976 | 1.33 | 1.64 | 7 | 9 | 2 | 0 | 100% | 1 |
| 3SWG_EPZ_A_518 | 90% | 20% | 0.053 | 0.977 | 1.8 | 1.56 | 9 | 11 | 0 | 0 | 100% | 1 |
| 6DNT_EPZ_A_402 | 88% | 59% | 0.057 | 0.975 | 0.73 | 0.66 | 2 | - | 1 | 0 | 100% | 0.99 |
